Subcutaneous insulin: A guide for dosing regimens in the hospital

Glycemic Control in the Hospitalized Patient: A Comprehensive Clinical Guide

Volumn , Issue , 2011, Pages 7-16

  Barnard, Karen ^a,b   Batch, Bryan C ^a,b   Lien, Lillian F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Basal insulin; Basal bolus insulin; Correction dose insulin; Prandial insulin; Total daily dose of insulin

Indexed keywords

EID: 84886032536     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60761-006-9_2     Document Type: Chapter

References (17)

1. American Diabetes Association. Diabetes care executive summary from the American Diabetes Association. Standards of medical care in diabetes 2009. Diabetes Care. 2009;32(suppl 1): S6-S12.
2. Campbell KB, Braithwaite S. Hospital management of hyperglycemia. Clin Diabetes. 2004;22(2):81-88.
3. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004; 27(2):553-591.
4. Hamann A, Matthaei S, Rosak C, Silvestre L for the HOE901/4007 Study Group. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes. Diabetes Care. 2003; 26(6):1738-1744.
5. Hirsch I, Pauw D, Brunzell J. Inpatient management of adults with diabetes. Diabetes Care. 1995; 18(6):870-878.
6. Inzucchi SE. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006; 355(18):1903-1911.
7. Kitabchi A, Freirea A, Umpierrez G. Evidence for strict inpatient blood glucose control: time to revise glycemic goals in hospitalized patients. Metabolism. 2008; 57(1):116-120.
8. Levetan C, Magee M. Hospital management of diabetes. Endocrinol Metab Clin N Am. 2000; 29(4):745-770.
9. Lien LF, Bethel MA, Feinglos MN. In-hospital management of type 2 diabetes mellitus. Med Clin N Am. 2004;88(4):1085-1105, xii.
10. Moghissi ES, Korytkowski MT, DiNardo M. American Association of Clinical Endocrinologist and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15(4):1-17.
11. Nathan D. Insulin treatment of type 2 diabetes mellitus. In: Prote D, Sherwin R, Baron A, eds. Ellenberg and Rifkin's Diabetes Mellitus. 6th ed. New York, NY: McGraw-Hill; 2003:515-522.
12. NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-1297.
13. Trence DL. Management of patients on chronic glucocorticoid therapy: an endocrine perspective. Prim Care. 2003;30(3):593-605.
14. Umpierrez GE, Andres P, Smiley D, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (Rabbit 2 trial). Diabetes Care. 2007;30(9):2181-2186.
15. Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin dose: myth or insanity. Am J Med. 2007;120(7):563-567 (Review).
16. Wesorick D, O'Malley C, Rushakoff R, Larsen K, Magee M. Management of diabetes and hyperglycemia in the hospital: a practical guide to subcutaneous insulin use in the non-critically ill, adult patient. J Hosp Med. 2008;3(suppl 5):S17-S28.
17. Wittlin S, Woehrle H, Gerich J. Insulin pharmacokinetics. In: Leahy J, Cefalu W, eds. Insulin Therapy. New York, NY: Marcel Dekker; 2002:73-85.